Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-26T09:07:55.659Z Has data issue: false hasContentIssue false
  • English
  • Français

X-ray powder diffraction analysis of a new palladium(II) amino acid complex

Published online by Cambridge University Press:  06 March 2012

Pedro P. Corbi ,
Antonio C. Massabni  and
Claudio M. Costa-Neto
Pedro P. Corbi*
Affiliation:
Departamento de Química Geral e Inorgânica, Instituto de Química-UNESP, Caixa Postal 355, 14801-970, Rua Prof. Francisco Degni, s/n, Araraquara, SP, Brazil
Antonio C. Massabni
Affiliation:
Departamento de Química Geral e Inorgânica, Instituto de Química-UNESP, Caixa Postal 355, 14801-970, Rua Prof. Francisco Degni, s/n, Araraquara, SP, Brazil
Claudio M. Costa-Neto
Affiliation:
Departamento de Bioquímica e Imunologia, Faculdade de Medicina de Ribeirão Preto-FMRP, Universidade de São Paulo–USP, 14049-900, Avenida Bandeirantes, 3900 Ribeirão Preto, SP, Brazil
*
a)Author to whom correspondence should be addressed; Electronic mail: pedrocorbi@yahoo.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Powder X-ray diffraction data for a new palladium(II) amino acid complex, of composition PdC12H20N2O4S2, are presented in this paper. Orthorhombic cell parameters are: a=10.740 Å, b=19.999 Å, and c=5.2470 Å. © 2004 International Centre for Diffraction Data.

Keywords

powder diffractionpalladium(II)amino acid
Type
New Diffraction Data
Information
Powder Diffraction , Volume 19 , Issue 3 , September 2004 , pp. 270 - 271
Copyright
Copyright © Cambridge University Press 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Butour, J. L., Wimmer, S., and Castan, P. (1997). “Palladium(II) compounds with potential antitumor properties and their platinum analogues: A comparative study of the reaction of some orotic acid derivatives with DNA in vitro,” Chem. Biol. Interact. CBINA8 104, 165–178. 435s, CBINA8 CrossRefGoogle ScholarPubMed
Jin, V. X.and Ranford, J. D. (2000). “Complexes of platinum(II) or palladium(II) with 1,10-phenantroline and amino acids,” Inorg. Chim. Acta ICHAA3 304, 38–44. ica, ICHAA3 CrossRefGoogle Scholar
Lebwohl, D.and Canetta, R. (1998). “Clinical development of platinum complexes in cancer therapy: An historical perspective and update,” Eur. J. Cancer EJCAEL 34, 1522–1534. 3ai, EJCAEL CrossRefGoogle ScholarPubMed
Moreira, A. G., Corbi, P. P., Massabni, A. C., and Costa-Neto, C. M. (2003). “Antiproliferative and cytotoxic effect of a new palladium complex on tumorigenic cells.” Book of Abstracts of the XXXII Annual Meeting of the Brazilian Bichemistry and Molecular Biology Society, MG-Brazil, J-31, 125 pp.Google Scholar
Powder Diffraction File Database (1996). 30-1556 (JCPDS-ICDD).Google Scholar
Powder Diffraction File Database (1994). 5-0681 (JCPDS-ICDD).Google Scholar
Powder Diffraction File Database (1994). 43-1024 (JCPDS-ICDD).Google Scholar
Sohn, Y. S., Baek, H., Cho, Y. H., Lee, Y., Jung, O., Lee, C. O., and Kim, Y. S. (1997). “Synthesis and antitumor activity of novel polyphosphazene-(diamine)platinum(II) conjugates,” Int. J. Pharm. IJPHDE 153, 79–91. hde, IJPHDE CrossRefGoogle Scholar